MIRM
MIRM
US6047491013
Mirum Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 521.312.000 336.888.000
54.7%
Cost of Revenue 100.240.000 81.643.000
22.8%
Gross Profit 421.072.000 255.245.000
65.0%
443.208.000 342.851.000
29.3%
Operating Income -22.136.000 -87.606.000
74.7%
Pretax Income -21.427.000 -86.912.000
75.3%
Net Income Common Stockholders -23.363.000 -87.942.000
73.4%
-- --
--
-- --
--
ende